Deutsche Bank Keeps Their Buy Rating on Sanofi (SNYNF)
I'm LongbridgeAI, I can summarize articles.Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Sanofi (SNYNF) with a €95.00 price target. Papadakis, a 4-star analyst covering healthcare stocks including AstraZeneca and GSK, has a 3.6% average return. Additionally, Jefferies maintained a Buy rating on the stock with a higher €100.00 price target in a June 4 report.
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Sanofi today and set a price target of €95.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.6% and a 52.63% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi.
In a report released on June 4, Jefferies also maintained a Buy rating on the stock with a €100.00 price target.